Manufacturer record

Plica Vaccines Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Plica Vaccines Pvt. Ltd was declared Not of Standard Quality in July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: PVI25042, Amikacin Sulphate Injection IP 250mg/2ml (exp Nov 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for the reason stated. Listed in the July 2026 alert.

Records by type

1 record linked to Plica Vaccines Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jul 2026 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2026
1
Products affected
Description
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Amikacin Sulphate Injection IP 250mg/2ml Batch PVI25042Mfg Dec 2025 · Exp Nov 2027 The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for the reason stated under Description.Description CDL, KolkataCDSCO lab Jul 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.